Article Text

Download PDFPDF
How can we increase offer rates of human papillomavirus (HPV) vaccination among men who have sex with men (MSM) in routine sexual health clinics?
  1. Alex Parr1,
  2. Nicolas Pinto-Sander2,
  3. Daniel Richardson1,2
  1. 1 Department of Sexual health and HIV medicine, Brighton & Sussex Medical School, Brighton, UK
  2. 2 Department of sexual health & HIV medicine, Brighton and Sussex University NHS Trust, Brighton, UK
  1. Correspondence to Dr Daniel Richardson, Brighton & Sussex University NHS Trust, Brighton BN2 5BE, UK; daniel.richardson{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In 2015, the Joint Committee on Vaccination and Immunisation recommended ‘A HPV-MSM immunisation programme should be introduced for MSM up to and including the age of 45 years who attend GUM and HIV clinics, subject to procurement of the vaccine and delivery of the programme at a cost-effective price’. Public Health England invited some genitourinary medicine (GUM) clinics to take part in a pilot study to evaluate the acceptability and feasibility of …

View Full Text


  • Handling editor Jackie A Cassell

  • Contributors DR designed the study. DR, AP and NPS collected and evaluated the data and contributed to the final write-up.

  • Funding None declared.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.